IMPACT OF ADJUNCT TREATMENT WITH MAITAKE-SX FRACTION ON GLYCEMIC CONTROL

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是验证这样一种假设，即该产品Maitake-SX部分将降低2型糖尿病患者的空腹血糖并改善糖耐量，而对非糖尿病患者没有显著影响。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to test the hypothesis that that the product, Maitake-SX fraction, will decrease fasting blood glucose and improve glucose tolerance in patients with type 2 diabetes, without a significant impact on patients without diabetes.